Home Blog

Blog

Pharma Marketing Blog

Featured posts

Google Ads Optimization for the Pharma Industry

Claudia Barbiero - December 13, 2024

Why Is FDA Issuing Fewer Marketing Violation Letters?

Claudia Barbiero - January 26, 2024

5 Strategies to Strengthen Relationships with HCPs

Pharma Marketing Network - January 3, 2024

Reuters Pharma USA 2023 Recap

Pharma Guy - April 5, 2023

Healthcare Businesswomen’s Association Appoints Mary Stutts as Chief Executive Officer

Pharma Guy - March 30, 2023

What is WOTY?

What’s WOTY?

Jennifer Ginest - May 13, 2022

ililli: How Social Audio is Driving HCP Engagement

Charles Benaiah - January 19, 2022

2022 Predictions From the Front-Lines of Pharma Digital Advertising

RJ Lewis - December 17, 2021

Ensemble by Happify Health

The First Prescription Digital Therapeutic for Anxiety & Depression

Pharma Guy - October 27, 2021

HBA’s Woman of the Year (WOTY): Defined

Pharma Guy - April 13, 2021

12 3 Page 1 of 3

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

April 17, 2026

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026